A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/08/1997	EP0799023A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/08/1997	EP0799022A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
10/08/1997	EP0799020A1 Cosmetic and dermatological preparations with flavonoids
10/08/1997	EP0798971A1 Increasing creatine and glycogen concentration in muscle
10/08/1997	EP0686159B1 Farnesyl:protein transferase inhibitors as anticancer agents
10/08/1997	EP0655062B1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors
10/08/1997	EP0652743B1 Oral compositions
10/08/1997	EP0595888B1 A process for the preparation of demethylepypodophyllotoxin
10/08/1997	EP0587554B1 A podophyllotoxin preparation containing triglycerides
10/08/1997	EP0584222B1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
10/08/1997	EP0580782B1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/08/1997	EP0559838B1 Ecteinascidins 736 and 722
10/08/1997	EP0544757B1 Novel polyamine conjugated oligonucleotides
10/08/1997	EP0506892B1 Boronated nucleosides
10/08/1997	CN1161697A Beta, beta'-dihydroxy meso-substituted chlorin, bacteriochlorin, isobacteriochlorin and method for making same
10/08/1997	CN1161696A Heterocycle substituted propenoic acid derivatives as NMDA antagonists
10/08/1997	CN1161695A Apolioprotein-B synthesis inhibitors
10/08/1997	CN1161694A Nucleoside derivatives and process for preparing same
10/08/1997	CN1161692A Di-tert-butylphenol compound with heterocyclic moiety, useful as anti-inflammatory agent
10/08/1997	CN1161652A Pharmaceutical compositions
10/08/1997	CN1161650A Process for making dosage units by wet granulation
10/08/1997	CN1161649A Competitive progesterone antagonists for regulating female fertility as required
10/08/1997	CN1161648A Methods for maintaining teeth and oral bone
10/08/1997	CN1161647A Compositions and method for controlling smoking
10/08/1997	CN1161337A Water soluble rapamycin esters
10/08/1997	CN1161336A Heteroatom-contg. cyclopentanopyridyl-oxazolidinones
10/08/1997	CN1161333A Novel heteroaryl-oxazolidinones
10/08/1997	CN1161330A Substd. quinazoline derivatives
10/08/1997	CN1161328A Aminoalkyl subsetd. benzo-heterocyclic compounds
10/08/1997	CN1161230A Medicine for treating centripetalis obesity
10/08/1997	CN1161225A Medical ointment for treating arthritis and hyperosteogeny
10/08/1997	CN1161220A Granule medicine for curing sterility due to sperm antibody
10/08/1997	CN1036067C Method for extracting protein and polysaccharide from spirulina and its use
10/08/1997	CN1036064C Method for preparing benzene derivatives with activity for improving the growth of NGF
10/08/1997	CN1036046C Prepn. of cantharidia liposoluble pharmaceutics
10/07/1997	US5675062 Mouse engrafted with histoincompatible artery which exhibits detectable arteriosclerosis with in 30 days of grafting
10/07/1997	US5675033 For treatment of skin disorders
10/07/1997	US5675027 Intermediates for making 4- (2-benzothiazolyl)methylamino!-α- (3, 4-difluorophenoxy)methyl!-1-piperidineethanol
10/07/1997	US5675024 Retinoid receptor agonists
10/07/1997	US5675013 1-hydroxy-6-substituted pyridine-2-ones and 1-hydroxy-6-substituted pyridine-2-thiones for biocidal use
10/07/1997	US5675008 Excitatory amino acid receptor antagonists
10/07/1997	US5675007 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands
10/07/1997	US5675004 Red-shifted tris-aryl-S-triazines
10/07/1997	US5675003 3-ammoniopropenyl cephalosporin compounds as antibacterial agents
10/07/1997	US5674998 C-4' modified adenosine kinase inhibitors
10/07/1997	US5674988 Inhibition of influenza virus neuraminidase
10/07/1997	US5674913 Method for assisting normal breathing in a mammal having a lung disorder
10/07/1997	US5674912 Sunscreen-wound healing compositions and methods for preparing and using same
10/07/1997	US5674911 Administering therapeutic drug dispersed in polyoxyethylene-polyoxypropylene copolymer surfactant
10/07/1997	US5674910 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
10/07/1997	US5674909 For treatment of cardiovascular disorders
10/07/1997	US5674907 Mercapto derivatives as inhibitors of nitric oxide synthase
10/07/1997	US5674904 Detoxification with 2-oxopropanedioic acid
10/07/1997	US5674903 Method of using citric acid for treating wrinkles
10/07/1997	US5674902 Administering 12-deoxyphorbol 13-monoester
10/07/1997	US5674901 Administering conjugated linoleic acids(or salts or esters) to benefit immune systems
10/07/1997	US5674899 Method of using lactic acid for treating wrinkles
10/07/1997	US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997	US5674896 Triglycerides having stearic acid residue at 2-position and other fatty acid residues containing two to ten carbons at the 1- and 3-positions, for mixing with foods or replacing other fat or oils
10/07/1997	US5674895 Time-released mixture containing oxybutynin or salt, polyalkylene oxide, hydroxypropylalkylcellulose, lubricant; drug delivery
10/07/1997	US5674894 Amidine derivatives useful as platelet aggregation inhibitors and vasodilators
10/07/1997	US5674893 Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor
10/07/1997	US5674892 Contacting with benzoxacyclotetradecin derivatives
10/07/1997	US5674890 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them
10/07/1997	US5674888 Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
10/07/1997	US5674887 Prevention of bone resorption
10/07/1997	US5674886 Triazolylated teritiary amine compound or salt thereof
10/07/1997	US5674885 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes
10/07/1997	US5674884 For treatment of serotonin-related disorders
10/07/1997	US5674882 Retroviral protease inhibiting compounds
10/07/1997	US5674881 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present
10/07/1997	US5674880 Tri-substituted phenyl derivatives and processes for their preparation
10/07/1997	US5674879 Compositions including and methods of using conformationally restricted angiotensin II antagonist
10/07/1997	US5674875 Method of blocking human 5-hydroxytryptamine-2 receptors
10/07/1997	US5674874 Anticancer agent
10/07/1997	US5674873 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
10/07/1997	US5674872 Treatment of ovarian cancer
10/07/1997	US5674871 Iontophoretic delivery of an antimigraine drug
10/07/1997	US5674870 Anti-cancer uses for barbituric acid analogs
10/07/1997	US5674869 Administering guanine derivative; treatment of hiv and herpes virus
10/07/1997	US5674868 Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists
10/07/1997	US5674866 Antiallergic imidazoazepines
10/07/1997	US5674864 N-substituted derivatives of α-mercapto alkylamines, their preparation process and the intermediates obtained, their use as medicaments and the compositions containing them
10/07/1997	US5674862 Methods of treating diabetic mellitus and its complications
10/07/1997	US5674861 Fluorinated steroids
10/07/1997	US5674860 Administering measured amounts of formoterol(or its salts or solvates) and budesonide by inhalation
10/07/1997	US5674858 Medicaments for treating gastrointestinal disorders
10/07/1997	US5674857 Use of hyaluronic acid to repair ischemia reperfusion damage
10/07/1997	US5674856 Modified oligodeoxyribonucleoditides
10/07/1997	US5674855 Intravenously administering protein- and peptide-free mixture containing cholanic acid or salt and a phospholipid
10/07/1997	US5674854 Mixing diclofenac or salt and beta-cyclodextrin forming inclusion complex in the form of slurry or paste by continuous mixing of the water, drying the product
10/07/1997	US5674853 Containing dietary polyunsaturated fatty acids and a saponin
10/07/1997	US5674852 Water-soluble retinoids
10/07/1997	US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
10/07/1997	US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same
10/07/1997	US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997	US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997	US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997	US5674533 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension
10/07/1997	US5674527 Multicompartment container for intravenous injection comprising fat in water emulsions, sugar in first compartment, peptides and electrolytes in second compartment; shelf life, stability

1 ... 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 6755 6756 6757 6758 6759 6760 6761 ... 7860